Oxipital AI Closes Series A Funding Led by SAS Private Equities

The company will use the funding to expand its operations and continue developing its products and technology.

The funding comes after a period of strong business growth as more manufacturers adopt Oxipital AI's V-CORTX platform to address labor shortages, improve product quality, enhance food safety, and reduce production delays.

The company expects its revenue to grow by 400% in 2026 driven by expanding partnerships with several global food manufacturers. It recently secured a major contract to deploy 120 AI vision systems using its V-CORTX platform to detect foreign objects across multiple production lines and facilities.

Oxipital AI's growth is driven by its V-CORTX platform, an AI vision system designed for complex manufacturing environments. The platform helps manufacturers improve product inspection, quality control, production efficiency, foreign object detection, and robotic automation, making it easier to deploy AI across production lines.

V-CORTX also provides production data and analytics that help manufacturers make informed decisions, maintain compliance, and track products throughout the manufacturing process. This gives companies a reliable and accountable way to use AI in daily operations.

"Machine vision has historically been one of the largest failure points in industrial automation," said Rory O'Driscoll, Partner at Scale Venture Partners. "Oxipital AI has built a fundamentally differentiated approach that is already proving itself in production at scale. Their traction with major food manufacturers demonstrates both the urgency of the problem and the size of the opportunity ahead."

"Food manufacturing is entering a new era," said Mark J. Chiappetta, President & CEO of Oxipital AI. "While automation is deployed at scale in highly structured industries like semiconductor fabrication and automotive, many others have been unable to benefit broadly because products and production conditions vary constantly.

About Oxipital AI

Founded in 2024, Oxipital AI is a Greater Boston-based company developing AI technology for manufacturing. Its V-CORTX platform helps automated systems see, understand and respond to changing production environments with human-like accuracy, improving efficiency, quality and reliability.